UBS Group Has Lowered Expectations for Keurig Dr Pepper (NASDAQ:KDP) Stock Price

Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) had its price target cut by investment analysts at UBS Group from $42.00 to $40.00 in a research note issued to investors on Thursday,Benzinga reports. The brokerage currently has a "buy" rating on the stock. UBS Group's price target would indicate a potential upside of 19.26% from the stock's current price.

KDP has been the subject of several other reports. Hsbc Global Res upgraded Keurig Dr Pepper from a "hold" rating to a "strong-buy" rating in a research note on Friday, April 25th. HSBC upgraded Keurig Dr Pepper from a "hold" rating to a "buy" rating and upped their price target for the stock from $36.00 to $42.00 in a research note on Friday, April 25th. Piper Sandler upgraded Keurig Dr Pepper from a "neutral" rating to an "overweight" rating and upped their price target for the stock from $35.00 to $40.00 in a research note on Wednesday, April 9th. Barclays dropped their price target on Keurig Dr Pepper from $38.00 to $37.00 and set an "overweight" rating for the company in a research note on Friday, June 27th. Finally, Argus began coverage on Keurig Dr Pepper in a research note on Wednesday, April 16th. They set a "buy" rating and a $40.00 price target for the company. Two analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $39.62.

Keurig Dr Pepper Trading Down 1.0%

Keurig Dr Pepper stock traded down $0.35 during trading on Thursday, hitting $33.54. The company's stock had a trading volume of 7,623,961 shares, compared to its average volume of 10,956,806. The stock has a market capitalization of $45.55 billion, a price-to-earnings ratio of 30.49, a P/E/G ratio of 2.56 and a beta of 0.47. The stock's fifty day moving average is $33.25 and its 200 day moving average is $33.17. Keurig Dr Pepper has a 1-year low of $30.12 and a 1-year high of $38.28. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.31 and a current ratio of 0.47.

Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) last released its earnings results on Thursday, April 24th. The company reported $0.42 EPS for the quarter, beating the consensus estimate of $0.38 by $0.04. The firm had revenue of $3.64 billion during the quarter, compared to analyst estimates of $3.57 billion. Keurig Dr Pepper had a return on equity of 10.86% and a net margin of 9.69%. The business's quarterly revenue was up 4.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.38 earnings per share. As a group, equities research analysts predict that Keurig Dr Pepper will post 1.92 EPS for the current year.

Insiders Place Their Bets

In related news, Director Robert James Gamgort sold 208,000 shares of the stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $34.12, for a total value of $7,096,960.00. Following the completion of the transaction, the director owned 2,846,490 shares of the company's stock, valued at approximately $97,122,238.80. This represents a 6.81% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, insider Mary Beth Denooyer sold 12,000 shares of the stock in a transaction dated Thursday, July 17th. The shares were sold at an average price of $33.66, for a total value of $403,920.00. Following the completion of the transaction, the insider directly owned 82,511 shares of the company's stock, valued at $2,777,320.26. This represents a 12.70% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 698,500 shares of company stock worth $23,557,560. Company insiders own 0.40% of the company's stock.

Institutional Trading of Keurig Dr Pepper

Several institutional investors and hedge funds have recently bought and sold shares of KDP. Vanguard Group Inc. raised its stake in Keurig Dr Pepper by 21.3% during the first quarter. Vanguard Group Inc. now owns 145,012,806 shares of the company's stock valued at $4,962,338,000 after buying an additional 25,425,644 shares in the last quarter. JPMorgan Chase & Co. raised its position in shares of Keurig Dr Pepper by 108.1% during the 1st quarter. JPMorgan Chase & Co. now owns 38,882,672 shares of the company's stock worth $1,330,565,000 after purchasing an additional 20,196,835 shares during the period. Price T Rowe Associates Inc. MD lifted its holdings in shares of Keurig Dr Pepper by 36.0% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 54,656,384 shares of the company's stock worth $1,755,564,000 after purchasing an additional 14,473,054 shares during the last quarter. Barrow Hanley Mewhinney & Strauss LLC lifted its holdings in shares of Keurig Dr Pepper by 65.0% in the 4th quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 21,219,771 shares of the company's stock worth $681,579,000 after purchasing an additional 8,363,192 shares during the last quarter. Finally, Norges Bank bought a new position in Keurig Dr Pepper during the 4th quarter worth $197,819,000. Institutional investors and hedge funds own 93.99% of the company's stock.

Keurig Dr Pepper Company Profile

Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.